Investor Relations
Corporate Governance
Board of Directors
Chairman
Stefano PellegrinoCEO
Giovanni GiulianiBoard Members
Mario FeraRoberto Ippolito
Giorgio Ortolani
Independent Board Members
Matteo AlminiDaniele Sotgiu
Board of Statutory Auditors
Chairman
Massimo D'AgostinoStanding Auditor
Paolo LombardoStanding Auditor
Agostino GaldiAlternate Auditor
Francesco TomasiAlternate Auditor
Luigi BorrelliAuditing Firm

Corporate Documents
Sustainability
Reports
Rating
- ESG Assessment Report produced by Cerved Rating Agency 2024
- ESG Assessment Report produced by Cerved Rating Agency 2023
- ESG Assessment Report produced by Cerved Rating Agency 2022
- ESG Assessment Report produced by Cerved Rating Agency 2021
- ESG Assessment Report produced by Cerved Rating Agency 2020
- ESG Assessment Report produced by Cerved Rating Agency 2019
Information for shareholders
Share Capital and Dividends
Extraordinary dividend
- Facsimile form for the bank
-
08/05/2025
Health Italia S.p.A. distributes a second extraordinary dividend in kind through the assignment of Rebirth S.p.A. shares
| Year | N. of Shares | Nominal Value | Share Capital | Dividend Unit | Monte Dividendi | Exchange |
|---|---|---|---|---|---|---|
| 2025 | 189.780 | N.A. | € 18.978.097,00 | n. 29 shares of the subsidiary Rebirth SpA for each Health Italia SpA share owned | n. 5,503,620 shares of the subsidiary Rebirth SpA (total amount € 9,906,516) | Mercato Euronext Growth Milan |
| 2024 | 189.780 | € 100,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
| 2023 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
| 2022 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
| 2021 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
| 2020 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato AIM |
| 2019 | 14.324.956 | € 1,00 | € 14.324.956,00 | An ordinary share for every 100 shares and € 0.025 for each ordinary share | € 354.552 e n. 141.820 ordinary shares | Mercato AIM |
| 2018 | 14.324.956 | € 1,00 | € 14.324.956,00 | € 0,082 | € 1.173.808,00 | Mercato AIM |
| 2017 | 12.371.530 | € 1,00 | € 12.371.530,00 | € 0,081 | € 1.001.266,00 | Mercato AIM |
| 2016 | 11.245.580 | € 1,00 | € 11.245.580,00 | 0,00€ | 0,00€ | Unlisted |
Shareholding
The share capital of Health Italia S.p.A. is equal to €18,978,097.00, represented by 189,780 ordinary shares, with no nominal value.
Updated on 27.01.2026.
From 1th July 2019 Health Italia stocks are negotiable with a minimum units lot.
There is no record of other shareholders apart from those listed above owning a share in the capital exceeding 5% that have notified Consob and Health Italia S.p.A. pursuant to art. 117 of Consob Regulation no. 11971/99 concerning the notification obligations for the relevant holdings.
Health Italia has met the requirements for the qualification of issuer with financial instruments distributed between the public to a significant extent pursuant to art. 2-bis of Consob Regulation no. 11971 of 1999. This qualification is effective starting from the 2020 financial year.
| Shareholding | Number of shares | % of ordinary capital |
|---|---|---|
| Lonvita S.p.A. | 129.814 | 68,40% |
| Own actions | 321 | 0,17% |
| Market | 59.645 | 31,43% |
From 1th July 2019 Health Italia stocks are negotiable with a minimum units lot.
There is no record of other shareholders apart from those listed above owning a share in the capital exceeding 5% that have notified Consob and Health Italia S.p.A. pursuant to art. 117 of Consob Regulation no. 11971/99 concerning the notification obligations for the relevant holdings.
Health Italia has met the requirements for the qualification of issuer with financial instruments distributed between the public to a significant extent pursuant to art. 2-bis of Consob Regulation no. 11971 of 1999. This qualification is effective starting from the 2020 financial year.
Significant Shareholders
Pursuant to the Euronext Growth Milan Regulation, anyone who holds at least 5% of a category of financial instruments of Health Italia S.p.A. he is a "Significant Shareholder".
Exceeding the 5% threshold and reaching or exceeding the 5%, 10%, 15%, 20%, 25%, 30%, 50%, 66.6% and 90% or the reductions below these thresholds, constitute a "Substantial Change" which must be communicated by Significant Shareholders to the administrative body of Health Italia SpA.
To this end, within 4 trading days, starting from the day on which the transaction that led to the Substantial Change was carried out, the Significant Shareholder must communicate to Health Italia S.p.A .:
- the identity of the Significant Shareholders involved;
- the date on which Health Italia S.p.A. has been informed;
- the date on which the Substantial Change of the investments took place;
- the nature and extent of the participation of the Significant Shareholder in the transaction.
Internal Dealing Communications
Assembly
2026th Documents
- Minutes of the Extraordinary General Meeting 23.01.2026
- Health Italia S.p.A.: Registration of the shareholders’ meeting resolution approving the amendment of the Articles of Association
- Withdrawal Form
- Notice of Convocation of the Extraordinary Shareholders’ Meeting 23.01.2026
- Proxy pursuant to art. 135-novies 23.01.2026
- Proxy pursuant to art. 135-undecies 23.01.2026
- Board of Statutory Auditors’ Report – Extraordinary Shareholders’ Meeting 23.01.2026
- Audit Firm’s Opinion 23.01.2026
- Valuation of the liquidation value of Health Italia S.p.A. shares
- Explanatory Report Extraordinary Meeting 01.23.2026
Research
- Banca Profilo - Health Italia company update - October 3, 2024
- Banca Profilo - Health Italia company update - 27 March 2024
- GBC - AG - Research Report (update) 09 November 2023 - EN
- GBC - AG - Research Report (update) 09 November 2023 - DE
- Banca Profilo - Health Italia company update - 27 September 2023
- GBC - AG - Research Report Initial Coverage 29 august 2023 - DE
- GBC - AG - Research Report Initial Coverage 29 august 2023 - EN
- Banca Profilo - Health Italia Initial Coverage - 04 august 2023
- Mediobanca - Well positioned to deliver healthy growth - 05 October 2021
- Mediobanca - Looking to keep the growth path found in 2020 - 09 June 2021
- Mediobanca - Profitability step-up needed to unlock upside - 10 July 2020
- Mediobanca - Moving further steps in nutraceutics - 7 Nov 2019
- Equity Research - FY18 Update - 4 Oct 2019
- Equity Research - H1 2018 Update - 11 Dic 2018
- Mediobanca - Initiation of Coverage - 28 Feb 2018
- Equity Research - Initiation of Coverage - 23 Mag 2017
- Equity Research - IPO - Integrated Health Plans and Services - 24 Nov 2016
Financial Reports
Below you can find the financial reports for the last two years:
Interim and periodic reports
- Health Italia consolidated half-yearly financial statements as of 30.06.2025
- Health Italia consolidated half-yearly financial statements as of 30.06.2024
- Health Italia consolidated half-yearly financial statements as of 30.06.2023
- Health Italia consolidated half-year financial statements at 30.06.2022
- Health Italia consolidated half-year financial statements at 30.06.2021
- Consolidated half-yearly financial report as of June 30, 2020 with KPMG report
- Consolidated half-yearly financial report as of June 30, 2019 with KPMG report
- Interim Consolidated Financial Statements at 30/06/2018 with KPMG report
- Consolidated Interim Financial Statements at 30/06/2018
- Consolidated Half Year Report at 30/06/2018
- Consolidated Half Year Report at 30/06/2017
- Interim consolidated financial statements at 30/06/2016
- Financial statements and consolidated financial statements as of 31/12/2024 with BDO Reports
- Financial statements and consolidated financial statements as at 31/12/2023 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2022 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2021 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2020 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2019 with KPMG reports
- Consolidated financial statements as at 31/12/2018 with KPMG report
- Consolidated financial statements as at 31/12/2018
- Financial statements as at 31/12/2018 with KPMG report
- Financial statements as at 31/12/2018
- Consolidated financial statement 31/12/2017
- Financial statement 31/12/2017
- Consolidated Financial Statements at 31/12/2016
- Financial statements at 31/12/2016
- Aggregate balance sheet at 31/12/2015
Financial Calendar
| DATE | EVENTS |
|---|---|
| 30 March 2026 | Board of Directors – approval of the draft statutory financial statements and consolidated financial statements as of 31 December 2025 |
| 29–30 April 2026 | Shareholders’ Meeting – approval of the statutory financial statements and presentation of the consolidated financial statements as of 31 December 2025 |
| 25 September 2026 | Board of Directors – approval of the half-year financial report as of 30 June 2026 |
Investor Relator
Livia Foglia
investor@healthitalia.comSpecialist

Euronext Growth Advisor

Corporate Broker

Auditor

Legal Advisor

Legal Advisor

Investor e Media Relations

Admission document
You must read and accept the following information before accessing this section of the website. Consider carefully before reading, accessing, or otherwise using the information provided below. By accessing this section of the website, you agree to be subject to the terms and conditions below, which may or may not be modified or updated and should, therefore, be read in full upon each access to this site. The admission document contained in this section of the website ("Admission Document") is an Admission Document regarding Euronext Growth Milan, an alternative capital market multilateral trading facility organised and managed by Borsa Italiana SpA, of the ordinary shares of HEALTH ITALIA SpA and has been prepared in accordance with Euronext Growth Milan Issuers' Regulations. The Admission Document and the Transaction described in it do not constitute an offer to the public of financial instruments or admission of financial instruments in a regulated market as defined by Legislative Decree 24 February 1998, no. 58, Consob Regulation 14 May 1999, no. 11971 and the equivalent provisions of law and regulations applicable abroad.
Access to this section of the Website, the Admission Document and any other information contained in the following pages is only permitted to individuals that:
Any "U.S. Person" as defined in the aforementioned paragraph is precluded from any access to this section of the Website, temporary or permanent download and saving of the Admission Document or any other information contained in this section of the Website. The information contained in this section of the website cannot be copied or forwarded. For no reason and under no circumstances, are you allowed to circulate, directly or through third parties, the Admission Document and any other information contained in this section of the website outside of Italy, particularly in the United States, Australia, Japan, Canada or Other Countries, or distribute the Admission Document to non-resident Italian citizens.
Regulation S of the United States Securities Act of 1933, as subsequently amended, defines a "U.S. Person" as:
To access this section of the website, the Admission Document and any other information contained in the following pages, I declare under my sole responsibility that I am resident in Italy and not domiciled or presently staying in the United States, Australia, Japan, Canada or Other Countries and that I am not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.
I confirm I have read and agree to the above Terms and Conditions
- are resident in Italy and who are not domiciled or in any case currently staying in the United States, Australia, Japan, Canada or any other country where the circulation of the Admission Document and/or of any such information that requires the approval of the local authorities or is in violation of local rules or regulations (“Other Countries”);
- they are not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.
Any "U.S. Person" as defined in the aforementioned paragraph is precluded from any access to this section of the Website, temporary or permanent download and saving of the Admission Document or any other information contained in this section of the Website. The information contained in this section of the website cannot be copied or forwarded. For no reason and under no circumstances, are you allowed to circulate, directly or through third parties, the Admission Document and any other information contained in this section of the website outside of Italy, particularly in the United States, Australia, Japan, Canada or Other Countries, or distribute the Admission Document to non-resident Italian citizens.
Regulation S of the United States Securities Act of 1933, as subsequently amended, defines a "U.S. Person" as:
- any physical person residing in the United States;
- "partnerships" and "corporations" established and organized according to the law in force in the United States;
- any property whose administrators or managers are a "U.S. Person";
- trusts whose trustee is a "U.S. Person";
- any agency, branch or subsidiary of a subject having its headquarters in the United States;
- non-discretionary accounts;
- other similar accounts (except properties or trusts), managed or administered confidentially on behalf of or for the benefit of a "U.S. Person";
- "partnerships" and "corporations" if (i) set up and organised according to the laws of any foreign jurisdiction; and (ii) constituted by a "U.S. Person" with the principal aim of investing in unlisted securities under the United States Securities Act of 1933, as subsequently amended, unless they are constituted or organized and owned by accredited investors (as defined in Rule 501 (a) of United States Securities Act of 1933) that are not natural persons, properties or trusts
To access this section of the website, the Admission Document and any other information contained in the following pages, I declare under my sole responsibility that I am resident in Italy and not domiciled or presently staying in the United States, Australia, Japan, Canada or Other Countries and that I am not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.
I confirm I have read and agree to the above Terms and Conditions
Health is the greatest strength of a civilised people
Keep in touch with us
Enter your email here to receive news from the world of Health Italia



